Overview

A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

Status:
COMPLETED

Trial end date:
2024-07-10

Target enrollment:

Participant gender:

Summary

Winlevi is the first topical anti androgen and sebum inhibitor approved for acne vulgaris. There is no study assessing Winlevi in combination treatment for acne .Therefore this study assesses Winlevi with Duac gel in combination to emulate real life practice.

Phase:

PHASE4

Details

Lead Sponsor:

Sun Pharmaceutical Industries Limited

Treatments:

Clascoterone
clindamycin phosphate benzoyl peroxide combination